Larsson L I, Grimelius L, Håkanson R, Rehfeld J F, Stadil F, Holst J, Angervall L, Sundler F
Am J Pathol. 1975 May;79(2):271-84.
Twenty-four endocrine pancreatic tumors were examined immunohistochemically for insulin, glucagon, gastrin and ACTH. In seven of these tumors, more than one peptide-hormone-containing cell type was observed. These seven tumors were also examined with conventional staining methods for the presence of A1, A2, and B cells. The results showed that these staining methods do not always distinguish between the different hormone-producing cell types of endocrine pancreatic tumors. In spite of the fact that several types of hormone-secreting cells were found in the tumors, the case histories described symptoms characteristic of hypersecretion of only one of the hormones. The hormone of the predominating cell type could not always explain the clinical symptoms. Our results indicate the endocrine pancreatic tumors often are multihormonal. Therefore, it would seem advisable to screen serum from all insuloma patients for a variety of peptide hormones.
对24个内分泌胰腺肿瘤进行了胰岛素、胰高血糖素、胃泌素和促肾上腺皮质激素的免疫组织化学检查。在这些肿瘤中的7个中,观察到不止一种含肽激素的细胞类型。还用传统染色方法对这7个肿瘤检查了A1、A2和B细胞的存在情况。结果表明,这些染色方法并不总能区分内分泌胰腺肿瘤中不同的激素产生细胞类型。尽管在肿瘤中发现了几种类型的激素分泌细胞,但病例记录描述的症状仅为一种激素分泌过多的特征。占主导地位的细胞类型的激素并不总能解释临床症状。我们的结果表明,内分泌胰腺肿瘤常常是多激素性的。因此,对所有胰岛素瘤患者的血清进行多种肽激素筛查似乎是可取的。